Hypothesis

Aging‑related calbindin‑D28K (CB) loss in basal forebrain cholinergic neurons (BFCN) triggers CaMKII‑dependent phosphorylation of L‑type voltage‑gated calcium channels (VGCCs), shifting Ca2+ influx toward high‑frequency, low‑amplitude events. This remodelling fuels rapid non‑mitochondrial buffering (via calmodulin and plasma‑membrane Ca2+ ATPases) while simultaneously suppressing mitochondrial Ca2+ uptake through up‑regulation of the mitochondrial calcium uptake 1 (MICU1) gatekeeper. The resulting phenotype explains the paradoxical increase in small‑load buffering and the deficit in large‑load handling observed in aged BFCN, linking CB depletion to selective vulnerability in Alzheimer’s disease.

Mechanistic Model

1. CB normally buffers microdomains near VGCCs, limiting CaMKII activation.
2. With CB depletion, local Ca2+ rises near Cav1.2 channels increase CaMKII autophosphorylation.
3. Phosphorylated CaMKII phosphorylates the β‑subunit of Cav1.2, favoring modes that open briefly and repeatedly.
4. These brief openings produce Ca2+ spikes that are efficiently seized by cytosolic calmodulin and expelled by PMCA/NCX, giving the appearance of enhanced rapid buffering.
5. Persistent low‑level CaMKII activity also increases transcription of MICU1 (via CREB), raising the threshold for mitochondrial calcium uniporter (MCU) activation.
6. Consequently, large Ca2+ loads (e.g., during excitotoxic challenge) cannot be taken up by mitochondria, leading to matrix overload, ROS production, and downstream tangle formation.

Predictions

• In aged BFCN, pharmacological inhibition of CaMKII will restore Cav1.2 gating to low‑frequency, high‑amplitude patterns and normalize mitochondrial Ca2+ uptake.
• Viral knock‑down of MICU1 in aged BFCN will rescue large‑load buffering without affecting the rapid‑buffer phenotype.
• CB‑repletion (via AAV‑CB) will blunt CaMKII activation and prevent both the rapid‑buffer increase and the mitochondrial deficit.
• These manipulations will reduce phospho‑tau accumulation and protect neurons from NMDA‑induced death in vitro and slow cognitive decline in aged rats.

Experimental Design

In vitro

• Isolate BFCN from young (3 mo) and aged (24 mo) rats.
• Treat aged cultures with CaMKII inhibitor (KN‑93) or control peptide.
• Measure VGCC open‑probability using patch‑clamp fluorometry ( Cav1.2‑β‑subunit FRET sensor ).
• Quantify rapid buffering with fluo‑4 decay after a brief depolarization (10 ms pulse) and mitochondrial buffering with Rhod‑2 after a prolonged depolarization (500 ms pulse).
• Assess phospho‑tau (AT8) and ROS (MitoSOX) after NMDA exposure.

In vivo

• Aged rats receive bilateral AAV‑shMICU1 or AAV‑CB injections into the nucleus basalis.
• After 4 weeks, perform in vivo two‑photon calcium imaging during a working‑memory task to gauge small‑ vs large‑scale Ca2+ transients.
• Evaluate tangle burden (AT8 immunostaining) and cognitive performance (Morris water maze).
• Include scrambled shRNA and GFP controls.

Falsifiability

If CaMKII inhibition does not alter VGCC gating kinetics, or if MICU1 knock‑down fails to improve large‑load buffering, the hypothesis is refuted. Likewise, if CB repletion does not reduce CaMKII activity or rescue both buffering phenotypes, the proposed causal chain is invalid.